Trendlines Group Ltd. engages in the investment and development of medical and agricultural technology companies. The company invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Group’ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.
根據最新的財務報表(Form-10K),The Trendlines Group Ltd. 的總資產為 $85,淨利潤為 $1
TRNGF 的關鍵財務比率是什麼?
The Trendlines Group Ltd. 的流動比率為 12.14,淨利潤率為 0,每股銷售為 $0。
The Trendlines Group Ltd. 的收入按細分市場或地理位置如何劃分?
The Trendlines Group Ltd. 最大收入來源為 Innovative Agrifood Tech and Medical Device,在最近的收益報告中收入為 -661,522。就地區而言,Israel 是 The Trendlines Group Ltd. 的主要市場,收入為 -661,522。